What are Acadia Pharmaceuticals's profit margins?

Acadia Pharmaceuticals (ACAD) runs a 91.5% gross margin and a 7.4% operating margin, with a 34.3% net margin.

Where do Acadia Pharmaceuticals's ratios come from?

Every ratio is computed from Acadia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Acadia Pharmaceuticals ACAD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	91.7%+0.2pp	91.5%-2.8pp	94.3%-3.8pp	98%+2.0pp
Operating margin	9.8%-14.3pp	24.1%—	——	-43.2%-8.0pp
Net margin	36.5%+12.8pp	23.6%+32.1pp	-8.4%+33.3pp	-41.8%-7.1pp
Returns
Return on equity	39.9%+1.0pp	38.9%+53.6pp	-14.7%+31.2pp	-45.9%-17.1pp
Return on invested capital	13.4%-39.5pp	52.9%—	——	-55.5%-13.4pp
Efficiency
Asset turnover	0.8×-0.2×	1×-0.1×	1.1×+0.3×	0.8×+0.2×
Liquidity
Current ratio	3.8×+1.5×	2.4×0.0×	2.4×-1.6×	4×-2.4×
Leverage
Debt-to-equity	0×0.0×	0.1×-0.1×	0.1×0.0×	0.2×0.0×
Net debt / EBITDA	-1.1×0.0×	-1.1×—	——	——
Per Share
Book value per share	$7.22+64.0%	$4.40+67.1%	$2.64+6.4%	$2.48-26.5%
Valuation
Market capitalization	$4.52B+48.0%	$3.05B-40.6%	$5.14B+99.4%	$2.58B-31.3%
Price / earnings	11.6×-1.9×	13.5×—	——	——
Price / sales	4.2×+1.0×	3.2×-3.9×	7.1×+2.1×	5×-2.8×
Price / book	3.7×-0.5×	4.2×-7.7×	11.9×+5.5×	6.4×-0.5×
EV / EBITDA	37.7×+26.4×	11.3×—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Acadia Pharmaceuticals's profit margins?: Acadia Pharmaceuticals (ACAD) runs a 91.5% gross margin and a 7.4% operating margin, with a 34.3% net margin.
Where do Acadia Pharmaceuticals's ratios come from?: Every ratio is computed from Acadia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.